Search Results for keywords:"Trade Secrets"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on March 19, 2021, from 11:30 a.m. to 2:00 p.m. The meeting is set to evaluate contract proposals and will be held virtually at the National Institutes of Health. It will remain closed to the public to protect confidential information, including trade secrets and personal data. Kelly L. Hudspeth, Ph.D., is the contact person for more details on the meeting.

The Center for Scientific Review at the National Institutes of Health has announced several upcoming closed meetings. These meetings, held virtually, are scheduled for April 22-23 and April 30-May 1, 2025, and will focus on reviewing and evaluating grant applications related to infectious diseases and immunology. The meetings will remain closed to protect sensitive information, including trade secrets and personal details associated with the grant applications. The Federal Advisory Committee Act guidelines are followed to ensure confidentiality.

The Agency for Healthcare Research and Quality (AHRQ) will hold a Special Emphasis Panel (SEP) meeting on January 10, 2025, focused on implementing and evaluating patient-centered clinical decision support strategies in real-world settings. This meeting, which will review grant applications, is closed to the public because it may involve confidential information. The discussions could involve trade secrets or private information that cannot be shared publicly to avoid privacy violations. The meeting will take place via video review at their location in Rockville, Maryland.

The National Eye Institute announced that a meeting will take place on February 2, 2021, for reviewing and evaluating grant applications as part of the BRAIN Initiative. The meeting will be closed to the public to protect confidential trade secrets and personal information pertaining to the grant applications. Participants will connect virtually, and the session will run from 12:00 p.m. to 3:30 p.m. Dr. Brian Hoshaw, a representative from the National Institutes of Health, can be contacted for more information regarding the meeting.

The National Institutes of Health announced several closed meetings in April 2025 to review and evaluate grant applications. These virtual meetings will gather different committees, such as the Oncology Basic Translational Integrated Review Group and the Cardiovascular and Respiratory Sciences Integrated Review Group, among others. The discussions will be closed to the public to protect confidential information, including trade secrets and personal data. The meetings are conducted under the Federal Advisory Committee Act's provisions, with specific contact persons listed for further inquiries.

The National Institutes of Health (NIH) announced a closed meeting for the National Institute of Allergy and Infectious Diseases Special Emphasis Panel. This meeting, set for January 7, 2025, will focus on reviewing and evaluating contract proposals related to using artificial intelligence to enhance clinical microscopy for diagnosing infectious diseases. Due to confidential matters concerning trade secrets and personal privacy, the meeting will not be open to the public, and it will take place virtually at the NIH's Rockville, MD location.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, scheduled for March 11, 2025. The meeting, which will be held via teleconference, will focus on reviewing and evaluating grant applications. It is closed to the public because discussions might reveal trade secrets, commercial property, or private information about individuals involved in the grant applications. For more details, interested parties are encouraged to contact Catherine Barrett, the Scientific Review Officer at the CDC.

The National Institute on Aging is holding a meeting of the Special Emphasis Panel called NIA SBIR/STTR. This meeting, scheduled for April 8-9, 2025, from 9:30 a.m. to 6:00 p.m., will be conducted virtually and is closed to the public. The purpose of this meeting is to review and evaluate grant applications, which may involve sensitive information like trade secrets or personal data about individuals. The meeting details, including contact information for the Scientific Review Officer, are provided for those who need it.

The U.S. International Trade Commission has concluded that SK Innovation Co., Ltd. violated section 337 of the Tariff Act of 1930 by improperly handling lithium ion battery trade secrets from LG Chem, Ltd. As a result, a limited exclusion order has been put in place, stopping certain lithium ion battery products from being imported, alongside cease and desist orders against the respondents. However, the orders allow SK to import certain necessary components for domestic battery production for Ford and Volkswagen for a limited time, and for specific Kia vehicles' replacement parts. This decision has been approved and filed with the President and the United States Trade Representative.

The National Institute of Allergy and Infectious Diseases is having a meeting on April 28, 2025, which will be closed to the public. The meeting will involve reviewing and evaluating grant applications which may include confidential trade secrets and personal information. This meeting will take place via video conference, and the contact person for more information is Vishakha Sharma, Ph.D. from the National Institutes of Health.